•
Mar 31, 2024

SelectQuote Q3 2024 Earnings Report

SelectQuote outperformed expectations for the 9th consecutive quarter and raised fiscal year 2024 guidance ranges.

Key Takeaways

SelectQuote reported consolidated revenue for the third quarter of fiscal year 2024 of $376.4 million and net income of $8.6 million. The company raised its fiscal year 2024 revenue guidance to a range of $1.25 billion to $1.3 billion and adjusted EBITDA to a range of $100 million to $110 million.

SelectQuote outperformed expectations for the 9th consecutive quarter.

Senior business completed a highly successful Medicare Advantage busy season, with over 185,000 Americans finding the right Medicare Advantage policy.

Healthcare Services business saw SelectRx grow by over 12,000 members, significantly exceeding the original outlook.

Holistic healthcare platform created new customers at a highly efficient revenue to customer acquisition cost of over 4x.

Total Revenue
$376M
Previous year: $299M
+25.7%
EPS
$0.05
Previous year: $0.06
-16.7%
Approved Medicare Adv Policies
185.72K
Submitted Medicare Adv Policies
226.69K
SelectRx Members
75.07K
Gross Profit
$186M
Previous year: $158M
+17.7%
Cash and Equivalents
$37.8M
Previous year: $92M
-58.9%
Free Cash Flow
$46.5M
Previous year: $62.3M
-25.4%
Total Assets
$1.25B
Previous year: $1.29B
-3.3%

SelectQuote

SelectQuote

SelectQuote Revenue by Segment

Forward Guidance

SelectQuote raised its fiscal year 2024 guidance ranges.

Positive Outlook

  • Revenue expected in a range of $1.25 billion to $1.3 billion vs prior range of $1.23 billion to $1.3 billion
  • Net loss expected in a range of $34 million to $21 million vs prior range of $45 million to $22 million
  • Adjusted EBITDA* expected in a range of $100 million to $110 million vs prior range of $90 million to $105 million

Challenges Ahead

Revenue & Expenses

Visualization of income flow from segment revenue to net income